Very interesting article in Springer Nature regarding Integrative Onclology interverentions for MPNs. It is helpful to see a review of evidence that support the positive experience some of us have experienced using some of these interventions.
Optimizing Care: Integrative Oncology in Myelopr... - MPN Voice
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm
Written by
hunter5582
To view profiles and participate in discussions please or .
1 Reply
•
Great article. Thank you for sharing.
Not what you're looking for?
You may also like...
The Role of New Technologies in Myeloproliferative Neoplasms
I was reviewing some of the items in my bookmarked resources and came across this article from...
Living with Myeloproliferative Neoplasm - ET Jak2+ and Chronic Neuropathic Pain
There is much money in the pain and drug industry. Ethics and the recipients of these drugs do not...
Phylogenetic reconstruction of myeloproliferative neoplasm reveals very early origins and lifelong evolution
« The mean latency between JAK2V617F acquisition and clinical presentation was 31 years (range...
MPN New Zealand Information and Support and MPN Australia & NZ Myeloproliferative Neoplasm Support Community - Facebook Groups
Hi everyone,
For those of you on here that are are in Australia and New Zealand I just wanted to...
Dual Vaccine Trial in Myeloproliferative Neoplasms
Brief Summary:
A phase I-II study in patients with mutated MPN by vaccinating with PD-L1 and...
Related Posts
Durability of Ruxolitinib for PV, Dr V in Targeted Oncology interview
BESREMi now recommended as a Preferred First-line Cytoreductive Therapy for PV in Updated NCCN Clinical Practice Guidelines in Oncology
New! advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms (MPN)
Serotonin as a therapeutic method for PV associated pruritis- New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
